Hepatitis C Virus Antigenic Convergence

Vaccine development against hepatitis C virus (HCV) is hindered by poor understanding of factors defining cross-immunoreactivity among heterogeneous epitopes. Using synthetic peptides and mouse immunization as a model, we conducted a quantitative analysis of cross-immunoreactivity among variants of...

Descripción completa

Detalles Bibliográficos
Autores principales: Campo, David S., Dimitrova, Zoya, Yokosawa, Jonny, Hoang, Duc, Perez, Nestor O., Ramachandran, Sumathi, Khudyakov, Yury
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279735/
https://www.ncbi.nlm.nih.gov/pubmed/22355779
http://dx.doi.org/10.1038/srep00267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279735/
https://www.ncbi.nlm.nih.gov/pubmed/22355779
http://dx.doi.org/10.1038/srep00267

Ejemplares similares